VERTEX PHARMDRN financial statements, including revenue, expenses, profit, and loss

The total revenue of VRTX34 for the last quarter is 13.31 B BRL, and it's 6.52% higher compared to the previous quarter. The net income of Q1 24 is 5.44 B BRL.